EcoDrugPlus

Ribosomal Protein S24

Ensembl ID : ENSDCDG00000030377
Gene Symbol: RPS24
3 Cross references
491 Possible Orthologues:

Ribosomal Protein S25

Ensembl ID : ENSDCDG00000034608
Gene Symbol: RPS25
3 Cross references
462 Possible Orthologues:

Ribosomal Protein S27

Ensembl ID : ENSDCDG00000032693
Gene Symbol: RPS27
3 Cross references
124 Possible Orthologues:

Ribosomal Protein S28

Ensembl ID : ENSDCDG00000025955
Gene Symbol: RPS28
3 Cross references
266 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSDCDG00000016379
Gene Symbol: RPS3A
3 Cross references
372 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSDCDG00000004529
Gene Symbol: RPS4X
3 Cross references
498 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSDCDG00000021616
Gene Symbol: RPS7
3 Cross references
370 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSDCDG00000033351
Gene Symbol: RPS8
3 Cross references
322 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSDCDG00000001127
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSDCDG00000024100
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSDCDG00000032758
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSDCDG00000033790
Gene Symbol: LOC114798173
3 Cross references
250 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).